UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read moreFri, 18th Sep 2015 09:23
UK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Scancell bases new facility at Oxford Science Park
Read moreIN BRIEF: Scancell doses first subject in Covidity phase one trial
Read moreTRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV
Read more(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.
Read more(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.
Read moreDIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares
Read moreTRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
Read moreIN BRIEF: Scancell turns once again to Durrant to lead company
Read more(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.
Read moreIN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK
Read moreIN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares
Read moreAIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact
Read moreIN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares
Read moreIN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares
Read more